Why Choose Hong Kong Adventist Hospital for Pediatric Vaccination?
As a private hospital aligned with international medical standards, Hong Kong Adventist Hospital delivers excellence in vaccine management and clinical care:
- Pharmaceutical Traceability & Origin Guarantee: Directly imported vaccines from original manufacturers in Finance, Italy, the United States, Belgium, and Ireland to ensure optimal potency and safety.
- Professional Nursing Assessment & Comprehensive Support (Nursing-led Care):
- In-Depth Pre-Vaccination Assessment: Experienced nurses conduct thorough evaluations of the child's allergy history, recent illnesses, and current medications to ensure they are in optimal health before administration.
- Dedicated Nursing Support & Remote Guidance: Specialist nurses are accessible via telephone or WeChat to answer post-vaccination queries (including fever management and injection site care).
- Pediatric Specialist Oversight: Assessments are personally conducted by pediatricians, providing not only vaccination but also comprehensive growth and developmental evaluations alongside expert medical consultations.
- Seamless Mainland Transition Plans: For children who started vaccinations in Mainland China, our medical team reviews immunization records to design a continuous schedule without duplicate doses.
- Premium Healthcare Environment: Private consultation rooms lower cross-infection risks compared to crowded public waiting areas.
Pediatric Vaccine Overview & Comparison
Hong Kong Adventist Hospital offers a comprehensive selection of pediatric vaccines aligned with International and Mainland standards. Parents may consult our pediatricians to customize a tailored vaccination program for their child.
|
Vaccine Type |
Applicable Age Range |
Recommended Schedule |
Mainstream Mainland China Availability |
Core Advantages |
|
6-in-1 Combination Vaccine |
≥6 weeks to 24 months |
Primary series: 2–3 doses (interval ≥4–8 weeks) Booster: 1 dose (≥6 months after primary series, recommended at 12–18 months) |
5-in-1 Vaccine + Hepatitis B Vaccine (administered separately) |
Fewer Injections: |
|
Meningococcal Group B Vaccine |
≥2 months (EMA / HK / Australia / Canada) |
Ages 2–5 months: 2–3 primary doses + 1 booster (12–15 months) Ages 6–11 months: 2 doses + booster Ages 12–23 months: 2 doses + booster Ages ≥2 years: 2 doses (interval ≥1 month) |
Not yet widely available |
Fills Critical Protection Gap: Provides targeted protection against Group B meningococcal strains, currently a main cause of disease in Mainland China. |
|
Meningococcal Conjugate Vaccine (MenACWY) |
FDA: ≥6 weeks |
6 weeks to <6 months: 4 doses (at 2, 4, 6, and 12–18 months) Ages 6–23 months: 2 doses (interval ≥3 months) Ages ≥2 years: 1 dose Booster (≥13 years): 1 dose (≥3 years since previous dose) |
MenA (Group A Meningococcal Polysaccharide Vaccine) |
Broad-Spectrum Protection: Protects against 4 serogroups (A, C, W, Y) and provides long-lasting immune memory. |
|
20-Valent Pneumococcal Conjugate Vaccine (PCV20) |
≥6 weeks |
Infant routine: 4 doses (at 2, 4, 6, and 12–15 months) Starting 7–11 months: 3 doses Starting 12–23 months: 2 doses Ages 2–17 years: 1 dose |
13-Valent Pneumococcal Conjugate Vaccine (PCV13) |
Expanded Coverage: Covers 7 additional pneumococcal serotypes compared to PCV13. |
|
MMRV Vaccine (ProQuad) |
FDA: ≥12 months |
2-dose series: Dose 2: 4–6 years (interval between doses: ≥3 months) |
MMR + Varicella (administered separately) |
4-in-1 Combination: |
|
Rotavirus Vaccine (Oral) |
From ≥6 weeks |
2-dose oral series: Dose 2: ≥4 weeks after Dose 1 |
Domestic Lanzhou Lamb Rotavirus Vaccine (LLR) |
Convenient Oral Dosing: Gentle oral administration requiring fewer doses while maintaining high protection against severe gastroenteritis. |
